Lepidic component identifies a subgroup of lung adenocarcinoma with a distinctive prognosis: a multicenter propensity-matched analysis

BACKGROUND: Our aim was to investigate the prognostic impact of the lepidic component on T stage in patients with lung adenocarcinoma (LUAD). METHODS: A retrospective data set including 863 cases of LUAD with lepidic component and 856 cases without lepidic component was used to identify matched lepi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Med Oncol
Autores principales: Zhu, Erjia, Dai, Chenyang, Xie, Huikang, Su, Hang, Hu, Xuefei, Li, Ming, Fan, Junqiang, Liu, Jinshi, Zhu, Quan, Zhang, Lei, Ke, Honggang, Chen, Chang
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7768877/
https://ncbi.nlm.nih.gov/pubmed/33488781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920982845
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares